Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Ebert

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Radiology|March 27, 2004
Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i studyPeter Reimer, Christoph Bremer, Thomas Allkemper, et al.
Investigative Radiology|November 3, 2023
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy AdultsBirte Maria Hofmann, Kai Riecke, Stefan Klein, et al.
Radiology|February 4, 2003
MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigsFrank K Wacker, Klaus Reither, Wolfgang Ebert, et al.
Academic Radiology|November 27, 2002
Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particlesFrank K Wacker, Michael Wendt, Wolfgang Ebert, et al.
NMR in Biomedicine|November 4, 2004
First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot studyBernd Tombach, Peter Reimer, Christoph Bremer, et al.
AJR. American Journal of Roentgenology|January 5, 2002
Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysabilityBernd Tombach, Christoph Bremer, Peter Reimer, et al.
Investigative Radiology|June 15, 2022
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast AgentJessica Lohrke, Markus Berger, Thomas Frenzel, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agentsDaniel D Schwert, Nicholas Richardson, Gongjun Ji, et al.
Radiology|March 8, 2005
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiencyLars Matuszewski, Thorsten Persigehl, Alexander Wall, et al.
Investigative Radiology|April 11, 2025
Pharmacokinetics, Safety, and Dialyzability of Gadoquatrane in Patients With Impaired Renal Function: A Comprehensive Investigation Using Clinical Trial Data, Modeling and Simulation, and In Vitro DataTommaso Fadini, Gabriele Sutter, Stefan Klein, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Radiology|March 27, 2004
Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i studyPeter Reimer, Christoph Bremer, Thomas Allkemper, et al.
Investigative Radiology|November 3, 2023
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy AdultsBirte Maria Hofmann, Kai Riecke, Stefan Klein, et al.
Radiology|February 4, 2003
MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigsFrank K Wacker, Klaus Reither, Wolfgang Ebert, et al.
Academic Radiology|November 27, 2002
Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particlesFrank K Wacker, Michael Wendt, Wolfgang Ebert, et al.
NMR in Biomedicine|November 4, 2004
First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot studyBernd Tombach, Peter Reimer, Christoph Bremer, et al.
AJR. American Journal of Roentgenology|January 5, 2002
Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysabilityBernd Tombach, Christoph Bremer, Peter Reimer, et al.
Investigative Radiology|June 15, 2022
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast AgentJessica Lohrke, Markus Berger, Thomas Frenzel, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agentsDaniel D Schwert, Nicholas Richardson, Gongjun Ji, et al.
Radiology|March 8, 2005
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiencyLars Matuszewski, Thorsten Persigehl, Alexander Wall, et al.
Investigative Radiology|April 11, 2025
Pharmacokinetics, Safety, and Dialyzability of Gadoquatrane in Patients With Impaired Renal Function: A Comprehensive Investigation Using Clinical Trial Data, Modeling and Simulation, and In Vitro DataTommaso Fadini, Gabriele Sutter, Stefan Klein, et al.
Pageof 3